ReportWire

Tag: Drug Enforcement Administration

  • THE DEA DECIDES TO RESCHEDULE MARIJUANA

    THE DEA DECIDES TO RESCHEDULE MARIJUANA

    [ad_1]

    In a historic move the Drug Enforcement Agency announced it plans to reschedule cannabis.  Monumental shift in the marijuana industry.

    After three years of waiting for President Biden to fulfill his promise of doing something about legal cannabis, the Drug Enforcement Agency (DEA) announced its plan to reschedule cannabis. This follows the recommendations from Health and Human Services (HHS) and the Food and Drug Agency (FDA).  They are sending their recommendation to the White House Office of Management and Budget for review of the impact on the budget. The shifts acknowledged the medical benefits of cannabis and can pave the way for PTSD treatment for veterans, something the President and Senator Patty Murray (D-WA).

    RELATED: Science Says Medical Marijuana Improves Quality Of Life

    “Moving to Schedule III is the single biggest thing that can happen to the US cannabis industry. It removes the 280E tax burden, increases medical research, and opens the investor base. Today is truly a tipping point for this burgeoning industry.” declared Jesse Redmond, Managing Director at Water Tower Research.

    “This historic move from the Biden Administration to reclassify cannabis from Schedule I to Schedule III reflects changes in the scientific and medical understanding of cannabis. It echoes moves in other countries around the world. Domestically, it lays the groundwork for federal tax benefits for the cannabis industry, as cannabis businesses will be treated like other businesses with regard to deductions and credits. It will also lower the costs and hurdles of conducting research on the plant and its products. Despite skeptics arguing that this spells the beginning of the end of the cannabis industry as we know, those doomsday scenarios fail to answer a basic question: why would the Biden Administration want to crack down on a substance that it classifies as “less dangerous” when it refused to crack down on the substance when it was a Schedule I substance? Little, if anything, will change at the state regulatory level, but that should not take away from the historic nature of this decision. Cannabis has been a Schedule I substance for 54 years, and despite multiple opportunities to reclassify it in decades’ past, today is the first time the US Government has been willing to say otherwise” shares John Hudak, Director, Maine Office of Cannabis.

    Hudak is widely respected in the industry and has been a thought leader for the growing industry. The move reclassifies cannabis from Schedule 1 of dangerous drug with zero medical benefits to to Schedule III such as ketamine, Tylenol with codeine, and anabolic steroids. The timing is still unsettled, but there is hope it will have an impact in 2024.  The industry as been struggling under schedule III despite a huge growth of consumers.  This will also open the door more for mainstream companies to become involved in the market.

    RELATED: Marijuana MicroDosing Can Improve Mundane Tasks

    “While this is great news for the cannabis industry, it’s too early to break out the Champagne,” said Lonnie Rosenwald, Partner at Zuber Lawler, LLP. “We don’t know yet when rescheduling will occur, or, perhaps more important, when the tax changes will take effect.  For companies and entrepreneurs considering entering the industry, rescheduling alone should provide an incentive to launch their businesses. But existing cannabis businesses will have to wait to see whether they’ll be able to deduct business expenses on their 2024 or 2025 returns. We expect answers to these questions in the coming weeks.” says Lonnie Rosenwald, an attorney for Zuber Lawler, a national law firm which covers the cannabis industry.

    This is a historic shift for the federal government and puts in more in line with the American Medical Association, most medical professionals, Canada and the general public.

     

    [ad_2]

    JJ McKay

    Source link

  • DEA Re-Hires Agent Who Was Fired for Taking CBD | High Times

    DEA Re-Hires Agent Who Was Fired for Taking CBD | High Times

    [ad_1]

    The Department of Justice has rescinded a DEA decision to fire a special agent who was let go due to a positive reading for CBD on a drug test.

    DEA special agent Anthony L. Armour will be re-hired as a special agent and be reimbursed for back pay and legal expenses after a years-long court battle that stretches back to 2019 when a routine drug test showed he had been using CBD, which Armour maintained in court was for the purpose of treating chronic pain in lieu of highly-addictive opioid based painkillers.

    “I’m excited to be getting back to work at DEA,” Armour said to The New York Times. “I hope to finish my career at DEA by helping its mission in taking dangerous drugs like fentanyl off the streets.”

    Armour’s battle with chronic pain goes back to an injury he sustained during his college football career. He was also injured on the job as a DEA agent in a car crash during a surveillance operation, after which he suffered from back pain and a sprained neck. He ordered CBD products and a vaporizer from the internet, under the impression that he was not taking any illegal risks as the 2018 Farm Bill federally legalized hemp products. 

    “For Armour and many others in this country, this change meant new opportunities—particularly as to CBD, a non-THC cannabinoid in the cannabis plant,” a portion of the lawsuit said. “Armour hoped CBD oils could play a role in his pain management. That he did is unsurprising. From Martha Stewart to Wrigley Field, CBD has become embedded in American culture.”

    After he failed the drug test, Agent Armour turned the CBD products he had ordered into his superiors. Under federal law, hemp-derived products are defined as such if they contain less than 0.3% THC (please follow these handy-dandy little hyperlinks if you want more information on the clusterfuck of loopholes the Farm Bill created with regard to hemp-derived cannabis products). Of the three different hemp-based products Agent Armour turned in, court documents showed that two of them tested within the 0.3% THC range but one of them tested above the allowed threshold at 0.35%, which could be due to the notoriously unreliable potencies of hemp products and the methods by which they are tested.

    The DEA even went so far as to double down on their decision years into the lawsuit in late August of 2023. They filed a court brief defending Agent Armour’s termination just days before the Department of Health and Human Services officially recommended the federal rescheduling of cannabis from Schedule 1 to Schedule 3. The DEA also issued an official notice to all DEA employees after Armour’s termination to avoid all CBD products despite their federally legal status.

    “Mr. Armour was an outstanding DEA agent when he took a chance in 2019. He believed it was unlikely that CBD products would cause him to test positive for marijuana, but he knew it was possible, and he bought those unregulated products on the internet and consumed them anyway,” the DEA brief said. “Mr. Armour argues that he ‘displayed negligence or poor decision-making,’ and DEA properly held him accountable for his poor decisions when they resulted in a verified positive drug test. DEA lost trust in Mr. Armour and properly removed him.”

    Despite a years-long fight to keep Agent Armour off the payroll the DEA has agreed to reinstate him and pay him $470,000 in back pay and legal fees, according to the New York Times who obtained a copy of the court filings from earlier this month. Agent Armour told the New York Times he still sees value in using CBD for pain management but that he will consult a medical professional for viable alternatives upon his return to work. 

    “Federal drug testing policies—and importantly, attitudes about drug testing—have not caught up with the times. I’m not the only career law enforcement officer in this country with chronic pain, nor am I the only law enforcement officer that has turned to legal cannabis products to address pain,” Agent Armour said in court testimony in September. “Nobody should have to choose between suffering pain and serving our country.”

    [ad_2]

    Patrick Maravelias

    Source link

  • Democrats urge Biden administration to deschedule marijuana – Cannabis Business Executive – Cannabis and Marijuana industry news

    Democrats urge Biden administration to deschedule marijuana – Cannabis Business Executive – Cannabis and Marijuana industry news

    [ad_1]





    Democrats urge Biden administration to deschedule marijuana – Cannabis Business Executive – Cannabis and Marijuana industry news





























    skip to Main Content

    [ad_2]

    AggregatedNews

    Source link

  • Federal Scientists Recommend Easing Restrictions on Marijuana – Cannabis Business Executive – Cannabis and Marijuana industry news

    Federal Scientists Recommend Easing Restrictions on Marijuana – Cannabis Business Executive – Cannabis and Marijuana industry news

    [ad_1]





    Federal Scientists Recommend Easing Restrictions on Marijuana – Cannabis Business Executive – Cannabis and Marijuana industry news





























    skip to Main Content

    [ad_2]

    AggregatedNews

    Source link

  • A timeline of what's happened since Colorado's first legal recreational marijuana sales began – The Cannabist

    A timeline of what's happened since Colorado's first legal recreational marijuana sales began – The Cannabist

    [ad_1]

    It’s been 10 years since Colorado launched the first legal recreational marijuana market in the world and became a pioneer in drug reform.

    But when it came to the nascent industry, the first sales on Jan. 1, 2014, were more a starting block than a finish line.

    In the decade since legalization, Colorado has refined laws, catalyzed new ones and served as a litmus test for the rest of the country as states followed its lead. Today, cannabis is recreationally available for sale in 24 states — where more than half of Americans live.

    Read the rest of this story on DenverPost.com.

    [ad_2]

    The Cannabist Network

    Source link

  • The first 10 years of legal marijuana in Colorado were a wild ride. What will happen in the next decade? – The Cannabist

    The first 10 years of legal marijuana in Colorado were a wild ride. What will happen in the next decade? – The Cannabist

    [ad_1]

    The world’s first legal sale of recreational marijuana happened in Denver on Jan. 1, 2014. In fact, it happened twice.

    Mason Tvert was managing the onslaught of media that descended on the Mile High City to witness the historic moment, set in motion by the successful legalization campaign he’d led. So many camera crews and reporters showed up that morning that Tvert decided to rotate two groups through the dispensary’s sales floor — with each transaction billed as the first time anyone 21 or older could legally buy weed simply by walking into a store, showing ID and paying for it, no doctor’s note necessary.

    Cannabis enthusiasts also flocked to downtown Denver that day. Lines outside the new rec stores stretched down city blocks. Buyers exited with purchases in hand, holding them overhead like victory trophies. Rumors even swirled that some stores had sold out, only adding to the fervor.

    Read the rest of this story on DenverPost.com.

    [ad_2]

    The Cannabist Network

    Source link

  • The Specter of Family Separation

    The Specter of Family Separation

    [ad_1]

    Almost as soon as Donald Trump took office in 2017, agents from Immigration and Customs Enforcement were dispatched across the country to round up as many undocumented foreigners as possible, and the travel ban put into limbo the livelihoods of thousands of people from majority-Muslim countries who had won the hard-fought right to be here—refugees, tech entrepreneurs, and university professors among them. The administration drew up plans for erecting a border wall, as well as an approach to stripping away the due-process rights of noncitizens so they could be expelled faster. These changes to American immigration policy took place in the amount of time that it would take the average new hire to figure out how to use the office printer.

    Explore the January/February 2024 Issue

    Check out more from this issue and find your next story to read.

    View More

    Within days of Trump’s election, his key immigration adviser, Stephen Miller, was already gathering a group of loyal bureaucrats to start drafting executive orders. Civil servants who were veterans of the George W. Bush administration found the proposals to be so outlandishly impractical, if not also harmful to American interests and perhaps even illegal, that they assumed the ideas could never come to fruition. They were wrong. Over the next four years, lone children were loaded onto planes and sent back to the countries they had fled without so much as a notification to their families. Others were wrenched from their parents’ arms as a way of sending a message to other families abroad about what awaited them if they, too, tried to enter the United States.

    If given another chance to realize his goals, Miller has essentially boasted in recent interviews that he would move even faster and more forcefully. And Trump, who’s been campaigning on the promise to finish the job he started on immigration policy, would fairly assume if he is reelected that harsh restrictions in that arena are precisely what the American people want. “Following the Eisenhower model, we will carry out the largest domestic deportation operation in American history,” he declared during a speech in Iowa in September, referring to 1954’s offensively titled Operation Wetback, under which hundreds of thousands of people with Mexican ancestry were deported, including some who were American citizens.

    Trump and other key fixtures of his time in office have refused to rule out trying to reinstate family separations. They have been explicit about their plans to send ICE agents back into the streets to make arrests (with help from the FBI, the Drug Enforcement Administration, and the National Guard), and finish their work on the wall. They say that they will reimpose the pandemic-related expulsion policy known as Title 42, which all but shut off access to asylum, and that they will expand the use of military-style camps to house people who are caught in the enforcement dragnet. They have laid out plans and legal rationales for major policy changes that they didn’t get around to the first time, such as ending birthright citizenship, a long-held goal of Trump’s. They’ve floated ideas such as screening would-be immigrants for Marxist views before granting them entry, and using the Alien and Sedition Acts in service of deportations. Trump and his advisers have also made clear that they intend to invoke the Insurrection Act to allow them to deploy the U.S. military to the border, and to use an extensive naval blockade between the United States and Latin America to fight the drug trade. That most drug smuggling occurs at legal ports of entry doesn’t matter to Trump and his team: They seem to have reasonably concluded that immigration restrictions don’t have to be effective to be celebrated by their base.

    The breakneck pace of work during Miller’s White House tour was periodically hampered by worried bureaucrats attempting end runs around him, or by his most powerful detractors, Ivanka Trump and Jared Kushner, whispering reservations into the president’s ear. But Trump’s daughter and son-in-law have left politics altogether, and Miller used Trump’s term to perfect strategies for disempowering anyone else who dared to challenge him. As for job applicants to work in a second Trump administration, Miller told Axios that being in lockstep with him on immigration issues would be “non-negotiable.” Others need not apply.

    Those who choose to join Trump in this mission to slash immigration would do so knowing that they would face few consequences, if any, for how they go about it: Almost all of the administration officials who pushed aggressively for the most controversial policies of Trump’s term continue to enjoy successful careers.

    The speed of Trump’s work on immigration can obscure its impact in real time. This is why Lucas Guttentag, a law professor at Stanford and Yale and a senior counselor on immigration issues in the Obama and Biden administrations, created a database with his students to log and track the more than 1,000 immigration-policy changes made during Trump’s years in office. Most remain in place. This is worth dwelling on. Trump’s time in office already represents a resurgence of old, disproven ideas about the inherent threat—physical, cultural, and economic—posed by immigrants. And if Trump does return to office, this moment may qualify less as a blip than an era: a period like previous ones when such misconceptions prevailed, and laws like the Chinese Exclusion Act and eugenics-based national-origins quotas ruled the day.

    Returning Trump to the presidency would reopen wounds that have barely healed in the communities he has said he would target immediately. Recently, I stood outside a church in the Northeast that caters mostly to undocumented farmworkers, with a Catholic sister who oversees the parish’s programming. As we stood in the autumn light, I remarked on the picturesque scene around her place of worship and work. She replied by pointing in one direction, then another, then another, at the places where she said ICE agents used to hide out on Sunday mornings during the Trump administration, waiting to capture her congregants as they left Mass to go about their weekly errands at the laundromat and the grocery store.

    Beyond the emotional impact of Trump’s return, the economy could also face a pummeling if the number of immigrant workers, legal and otherwise, were to drop. In a November 2022 speech, Jerome Powell, the chair of the Federal Reserve, detailed the harm from COVID-related dips in immigration, which left the country short an estimated 1 million workers.

    America’s rightward shift on immigration is part of a global story in which Western countries are, in general, turning against immigrants. But the world tends to look to the United States as a guide for what sorts of checks on immigration are socially permissible. A new Trump administration would provide a pretty clear answer: just about any.

    An anything-goes approach to immigration enforcement may indeed be what the country is left with if Trump succeeds in the next general election. “The first 100 days of the Trump administration will be pure bliss,” Stephen Miller told Axios, “followed by another four years of the most hard-hitting action conceivable.”


    This article appears in the January/February 2024 print edition with the headline “The Specter of Family Separation.”

    [ad_2]

    Caitlin Dickerson

    Source link

  • DEA Marijuana Rescheduling Likely By Next Year – Medical Marijuana Program Connection

    DEA Marijuana Rescheduling Likely By Next Year – Medical Marijuana Program Connection

    [ad_1]

    WASHINGTON DC – A former Food and Drug Administration official says he’d be “shocked” if the DEA does not reschedule cannabis by next year’s presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation to ease restrictions on cannabis by reclassifying it as a Schedule III drug under the Controlled Substances Act.

    Many political observers, and probably millions of voters, wonder what is going through President Biden’s head as the vast majority of the country shows support for marijuana legalization, Sklamberg also sounded dismayed.

    After Ohio’s historic decision on Tuesday to legalize recreational cannabis, more than half of the country now resides in a legal weed state, having gone from 49.2% of the population to 52.7%, and up to 80% if medical marijuana states are added in. And then there’s a Gallup poll that came out this week, which showed that seven in 10 Americans of all political, racial, gender and demographic stripes now think marijuana use should be legal….

    Original Author Link click here to read complete story..

    [ad_2]

    MMP News Author

    Source link

  • The Future of Mental-Health Drugs Is Trip-Free Psychedelics

    The Future of Mental-Health Drugs Is Trip-Free Psychedelics

    [ad_1]

    One of my chronically depressed patients recently found a psychoactive drug that works for him after decades of searching. He took some psilocybin from a friend and experienced what he deemed a miraculous improvement in his mood. “It was like taking off a dark pair of sunglasses,” he told me in a therapy session. “Everything suddenly seemed brighter.” The trip, he said, gave him new insight into his troubled relationships with his grown children and even made him feel connected to strangers.

    I don’t doubt my patient’s improvement—his anxiety, world-weariness, and self-doubt seemed to have evaporated within hours of taking psilocybin, an effect that has continued for at least three months. But I’m not convinced that his brief, oceanic experience was the source of the magic. In fact, some neuroscientists now believe that the transcendent, reality-warping trip is just a side effect of psychedelics—one that isn’t sufficient or even necessary to produce the mental-health benefits the drugs seem to provide.

    For several years, researchers have understood that the hallucinatory effects of psychedelics can, in theory, be separated from the other ways the drugs affect our mental state and brain structure. But until recently, they have not been able to design a psychedelic that reliably produces only the neurocognitive effects and not the hallucinatory ones. That may soon change. A new generation of nonhallucinogenic psychedelics, at least one of which is currently being tested in humans, aims to provide all of the mental-health benefits of LSD, psilocybin, or Ecstasy without the trip. Trip-free psychedelics would be a great therapeutic boon, dramatically expanding the number of people who can experience the benefits of these drugs. They might also shed new light on how much psychedelics can alleviate psychic distress—and why they do so at all.

    Over the past five years, studies have demonstrated that psilocybin has powerful antidepressant effects, and that MDMA (a.k.a. Ecstasy), in conjunction with psychotherapy, can relieve the symptoms of PTSD. Remarkably, just a few doses of either psilocybin or MDMA can produce a rapid, lasting improvement in depression and anxiety symptoms, meaning symptom relief within minutes or hours that lasts up to 12 weeks. (MDMA is what psychiatrists call an “atypical psychedelic”; it has a mix of psychedelic-like and amphetamine-like effects, producing a feeling of bliss rather than a transcendent or mystical state.) The FDA is widely expected to approve MDMA for supervised use sometime in 2024—an extraordinary turnabout for drugs that have long been stigmatized for their potential (if rare) serious harms.

    From a clinical perspective, this psychedelic revolution is potentially miraculous. An estimated 23 percent of Americans have a mental illness, and a considerable number of them, like my patient, don’t get sufficient relief from therapy or existing medications. Drugs like psilocybin, ayahuasca, and LSD could help many of these patients—but others won’t be able to tolerate the trip. (By “trip,” I mean the variety of altered mental states that psychedelic drugs can cause, such as the transcendence and mystical experience of LSD and psilocybin, and the bliss and social openness of MDMA.) Drug-induced hallucinations are known to give certain people—like those with psychotic disorders or severe personality disorders—extreme anxiety or even lead to a psychotic break. That’s why clinical trials of psychedelics typically exclude those patients.

    I don’t mean to discount the delight and power of a transcendent hallucination. Many people who’ve tripped on psychedelics describe the experience as among the most meaningful of their life. And in several studies of psilocybin for depression, the intensity of the trip correlates with the magnitude of the therapeutic effect. A trip is an extraordinary, consciousness-expanding experience that can offer the tripper new insight into her life and emotions. It also feels pretty damn good. But it’s far from the only effect the drugs have on the human brain.

    During a trip, psychedelics are silently doing something even more remarkable than warping reality: They are rapidly inducing a state of neuroplasticity, in which the brain can more easily reorganize its structure and function. (Microdosing enthusiasts, who take subtherapeutic doses of drugs like psilocybin, claim to experience enhanced creativity. They may be getting neuroplastic effects without a trip, but as yet, little scientific evidence backs up that idea.) Neuroplasticity enhances learning, memory, and our ability to respond and adapt to our environment—and could be central to the therapeutic effects of psychedelics. In depression, for example, the prefrontal cortex (the brain’s reasoner in chief) loses some of its executive control over the limbic system (the brain’s emotional center). Drugs that enhance neuroplasticity allow new connections to be formed between the regions, which can help reset the relationship and put the prefrontal cortex back in control of emotion.

    Like MDMA, ketamine—the animal tranquilizer, surgical anesthetic, and dissociative party drug that was also approved as a rapidly acting antidepressant in 2019—typically doesn’t produce hallucinations. But it does create a dissociative mental state, and it’s known to make neurons sprout new spines within hours of administration, a structural change that’s been linked with a reduction in depression-related behavior in animals. In humans, ketamine has been shown to boost mood—even if it’s administered when patients are unconscious. Several studies show that patients who receive ketamine during surgery wake up happier than they were before the operation. This suggests that you don’t need to consciously experience the dissociative effects in order to get the antidepressant benefits.

    Scientists are on their way to finding out for sure. For the first time, researchers have purposively developed psychedelic drugs that appear to bring about the neuroplastic effects without producing a trip. These drugs stimulate the same serotonin receptor as traditional psychedelics: 5-HT2A, which, when triggered, causes the brain to produce more of a compound called BDNF, a kind of brain fertilizer that promotes neuronal growth and connectivity. But the nonhallucinogenic versions activate 5-HT2A without leading to a trip. (Binding and activating receptors isn’t an all-or-nothing phenomenon; different drugs can bind the same receptor in different ways, producing very different effects.)

    Some of these trip-free psychedelics are new inventions. Last year, for example, scientists synthesized a new nonhallucinogenic psychedelic by imitating lisuride, an analog of LSD. (An analog is a chemical that is structurally very similar to the original compound, but has been modified to have a different function.) It doesn’t have a name yet—just a serial number, IHCH-7113—but it’s being studied in animals.

    Other trip-free psychedelics have been around for decades, if not recognized as such: 2-Br-LSD, another nonhallucinogenic analog of LSD, was first synthesized in 1957 by the same chemist who created LSD. (It was meant to treat migraine.) Recent experiments show that 2-Br-LSD, like LSD, relieves depressive behavior in mice. But unlike LSD, it doesn’t make the mice twitch their heads—a sign that a substance will give humans hallucinations and other psychotic symptoms. More than 60 years after 2-Br-LSD’s invention, the Canadian company BetterLife Pharma is planning to study it as a treatment for major depression and anxiety.

    LSD isn’t the only psychedelic inspiring imitators. Delix Therapeutics, a biotech company based in Boston, is using animal models to study tabernanthalog, which is an analog of the active psychedelic in ibogaine. Tabernanthalog has acute antidepressant and neuroplastic effects in animal models, and, like 2-Br-LSD, it doesn’t cause head twitching. Delix is also testing a drug that it’s calling DLX-1, which David Olson, one of Delix’s co-founders, told me is the first nonhallucinogenic psychedelic to be tested in humans; Phase 1 studies, he said, are nearly completed. Olson, who is also the director of the Institute for Psychedelics and Neurotherapeutics at UC Davis, calls the drugs he works on “psychoplastogens,” for their rapid neuroplasticity-inducing effects. He said that other nonhallucinogenic psychoplastogens that the company is working on are “close to entering clinical trials,” though how soon any of them might reach the market is unclear.

    As of yet, the federal government has provided little funding for nonhallucinogenic-psychedelics research. Delix and other makers of these new psychedelics will have to submit an application to the FDA to get their drug approved, which generally requires that the new drug beats a placebo control in two randomized clinical trials. This can be a slow process, but the FDA can expedite it by designating the drug a “breakthrough therapy,” which is exactly what it did in 2018 with psilocybin.

    In clinical trials, nontrip psychedelics will have at least one major advantage over their trip-inducing analogs: They can more easily be placebo-tested. Classic psychedelic research has been bedeviled by the simple fact that it is virtually impossible not to know that you are taking a classic psychedelic. Indeed, in clinical trials of MDMA and psilocybin, more than 90 percent of subjects who received the treatment correctly guessed that the drug they were given was real. This sort of defeats the purpose of placebo-testing psychedelics at all, because participants who receive the real drugs will expect to feel better. But the new nontrip psychedelics don’t produce the transcendent mental states that tend to “unblind” research subjects. They might produce more typical drug side effects, such as dry mouth or sedation, but that’s a far cry from a mystical experience.

    Nontrip psychedelics may also have it easier with respect to regulation. If they don’t make you high or produce a transcendent state, they’ll likely have little appeal as recreational drugs. The Drug Enforcement Administration classifies LSD and psilocybin as Schedule I drugs, which makes them difficult for researchers to study and doctors to prescribe. Even ketamine is Schedule III and must be administered in a medical setting, which may be inconvenient for patients. Perhaps the DEA will take more kindly to nontrip psychedelics; if so, they’d be easier to access for patients and researchers alike. Plus, nonhallucinogenic psychedelics would not require the time and expense of a guide to monitor the experience. All said, the nontrip psychedelics might end up being a more popular, better-researched choice than traditional ones.

    If the FDA really does approve MDMA next year, psychiatrists will have plenty of reason to celebrate. But I suspect that the future of psychedelic medicine will lean toward the wonder of pure neuroplastic potential and away from transcendence. Psychedelic trips will probably never disappear from society—for one thing, they are viewed as essential to some religious and cultural rituals. But perhaps they’ll come to be seen as less like therapy, and more like good old-fashioned fun.

    [ad_2]

    Richard A. Friedman

    Source link

  • Moving Marijuana to Schedule III Would Aid Access to Legal Care – Cannabis Business Executive – Cannabis and Marijuana industry news

    Moving Marijuana to Schedule III Would Aid Access to Legal Care – Cannabis Business Executive – Cannabis and Marijuana industry news

    [ad_1]





    Moving Marijuana to Schedule III Would Aid Access to Legal Care – Cannabis Business Executive – Cannabis and Marijuana industry news





























    skip to Main Content

    [ad_2]

    AggregatedNews

    Source link

  • ‘This isn’t some random dude with a duffel bag’: To catch fentanyl traffickers, feds dig into crypto markets | CNN Politics

    ‘This isn’t some random dude with a duffel bag’: To catch fentanyl traffickers, feds dig into crypto markets | CNN Politics

    [ad_1]


    Washington
    CNN
     — 

    The Biden administration has intensified its focus on tracing cryptocurrency payments that some of the most dangerous Mexican drug cartels use to buy fentanyl ingredients from Chinese chemical companies, the latest step in a renewed attempt to crack down on the multibillion-dollar fentanyl trade that kills thousands of Americans each year.

    The use of digital currency has exploded among fentanyl traffickers, with transactions for fentanyl ingredients surging 450% in the last year through April, according to data from private crypto-tracking analysis firm Elliptic.

    Federal agents are doing everything they can to catch up. While US diplomats have made fentanyl a point of emphasis in high-level talks with Mexican and Chinese counterparts, behind the scenes, a multi-agency effort is underway to keep pace with the rapidly changing nature of how fentanyl is financed and trafficked into the US. The work goes beyond the cartels to include tracking dark-web forums where Americans buy fentanyl.

    Current and former law enforcement officials from across the federal government described to CNN the digital-first tactics the administration is developing to disrupt the fentanyl trade.

    The Drug Enforcement Agency is investing in crypto-tracing software and identifying the cartels’ most sophisticated money launderers. The IRS has its most tech-savvy agents tracing payments on dark web forums. And a Department of Homeland Security investigations unit is leading a team of forensic specialists to pore over digital clues from stash houses near the Mexican border.

    Federal agents have been tracking the cartels’ finances and supply routes for years, but DHS, in particular, has ramped up its surveillance efforts in recent weeks, multiple US officials told CNN.

    There have been some notable busts recently, including nearly five tons of fentanyl seized this spring along the border. But there is still a lot of work left to do, officials caution, and the impact of the current surge may not be felt for months down the road.

    Agents have focused on the activities of two Mexican cartels, Sinaloa and Jalisco New Generation Cartel (CJNG), which officials say account for the majority of fentanyl on US streets. Sinaloa Cartel, in particular, has developed sophisticated crypto operations to finance its fentanyl business.

    “We’re dealing with a Fortune 50 company, which is what the Sinaloa Cartel is,” a US official with knowledge of the matter told CNN. “This isn’t some random dude with a duffel bag” selling fentanyl in daylight.

    Cryptocurrency has enhanced cartels’ ability to smuggle fentanyl into the US by allowing them to move vast sums of money instantaneously across a decentralized, digital banking system – all without having to deal with actual banks.

    “The speed the criminals can muster, it’s very hard for law enforcement to keep up,” said one top DEA official, who spoke to CNN on condition of anonymity to describe the agency’s counter-narcotics work.

    Cash is still king for the cartels and often preferred for local operations. But the expanded use of digital currency at both the supply and demand ends of the drug trade has made some traditional law enforcement methods obsolete. For example, drug dealers might hold fewer in-person meetings to hand over cash, reducing the opportunities for stakeouts by federal agents, said Jarod Koopman, head of the IRS’s Cyber and Forensics Services division.

    Cryptocurrency “eliminates the potential for hand-to-hand transactions,” said Koopman, whose team focuses on illicit financial flows, including dark-web purchases that are multiple steps removed from when the cartels get the drugs over the US border. “So now it’s … in a different world where some of the contacts might be online and we’re trying to facilitate or do transactions in a different manner.”

    But digital money also leaves a trail that investigators can follow.

    Federal agents have found cryptocurrency addresses written down on scraps of paper at stash houses in Arizona, Scott Brown, special agent in charge for Homeland Security Investigations (HSI) in that state, told CNN.

    In another case, DHS agents monitored a cartel-connected crypto account for over a year until it sent $200,000 to an accountant they were using to launder money, Brown said. After the accountant used the money to buy property in the US, federal agents are working to seize the property, he said.

    A “significant portion” of fentanyl is sold over the dark web and paid for in cryptocurrency, Brown said, adding: “That is a vulnerability that we can attack much like we attack the money movements in a traditional narcotics investigation.”

    Most of the fentanyl that enters the US comes from ingredients made in China that are then pressed into pills – or packed in powder – and smuggled in from Mexico by drug cartels, according to the DEA.

    A US indictment unsealed in June illustrates the scope of the problem. Just one Chinese chemical company allegedly shipped more than 440 pounds of fentanyl to undercover DEA agents in exchange for payment in cryptocurrency. It was enough drugs to kill 25 million Americans, according to prosecutors.

    The two cartels, Sinaloa and CJNG, have used their control of the fentanyl trade to develop sophisticated money-laundering techniques that exploit cryptocurrency, according to US officials.

    “We’ve identified people in the cartels that specialize in cryptocurrency movements,” the senior DEA official told CNN, describing longstanding efforts to surveil both the cartels.

    The Sinaloa Cartel has made hundreds of millions of dollars from the fentanyl trade, according to the Justice Department. Run by the sons of imprisoned drug lord Joaquín “El Chapo” Guzmán, the cartel has allegedly used airplanes, submarines, fishing boats and tractor trailers to transport fentanyl chemicals and other drugs. Four of the “Chapitos,” as Guzmán’s sons are known, are under indictment in the US for fentanyl trafficking, money laundering and weapons charges.

    With their father in jail, the younger generation of Sinaloa leaders is making more of an effort to cover their tracks and avoid law enforcement scrutiny, including by using cryptocurrency, the senior DEA official told CNN.

    In one case, the Sinaloa Cartel laundered more than $869,000 using cryptocurrency between August 2022 and February 2023, according to a US indictment unsealed in April. But that was likely just a fraction of the Sinaloa money laundered during that time, based on the huge profits the cartel has made in recent years.

    The scheme involved two of the cartel’s top money launderers directing US-based couriers to pick up cash from fentanyl traffickers and deposit the money to cryptocurrency accounts controlled by the cartel, the indictment said.

    “Not every seizure is going to get you to Chapo Guzman,” said Brown, the DHS official in Arizona. “It’s certainly more impactful when we can go after the people that are behind the production of the drugs, behind the production of the precursors, behind the movement of the money, behind running the transportation cells.”

    That’s why Brown and his colleagues are trying to make the most of a huge series of fentanyl busts in Arizona and California this spring, when agents seized nearly five tons of the deadly drug, worth over $100 million.

    Evidence was quickly shipped to a forensics lab in Northern Virginia, where DHS analysts hunted for digital clues – things like a common cell phone number called by drug runners near border towns or, better yet, a cryptocurrency account connected to one of the Mexican cartels, according to Brown.

    Based in Phoenix, Brown’s office oversees a recently announced federal task force that aims to thwart drug sales online by infiltrating dark-web forums and tracking crypto payments. The goal is to find “another vulnerability [in] the larger cartel infrastructure” that agents can attack, he said.

    The cartels “are very willing to invest in technology,” Brown said. “That’s one of the things that we need to be equally willing to do.”

    Crypto-based transactions can be traced publicly, giving US officials a much clearer picture of the Mexican cartels’ reliance on Chinese chemical companies to produce fentanyl.

    The Chinese government banned the sale of fentanyl in 2019. But Chinese chemical companies have since shifted to making fentanyl ingredients instead of the finished product, according to US officials and outside experts.

    A recent CNN investigation dug into the activities of US-sanctioned Chinese chemical companies that advertise fentanyl ingredients. When one sanctioned company shut down, another company launched, and told CNN it purchased the sanctioned company’s email, phone number and Facebook page to “attract internet traffic.”

    While the amount of fentanyl directly mailed to the US from China fell dramatically following the 2019 Chinese ban, according to a Brookings Institution study, US officials say Chinese companies are still producing and exporting large quantities of fentanyl ingredients.

    This January 2019 photo shows a display of fentanyl and meth that was seized by federal officers at the Nogales Port of Entry.

    Chinese companies selling ingredients to make fentanyl have received cryptocurrency payments worth tens of millions of dollars over the last five years, enough to potentially produce billions of dollars’ worth of fentanyl sold in the US and other markets, according to research from crypto-tracking firms.

    One of the firms, London-based Elliptic, found 100 China-based chemical companies touting fentanyl, fentanyl ingredients or equipment to make the drugs that accepted payments in cryptocurrency.

    Elliptic didn’t identify any cartel-controlled crypto accounts that sent money to the Chinese companies. That could be due to the cartels’ use of middlemen to buy ingredients and the fact that fentanyl traffickers in Europe also buy from the Chinese companies, according to US officials and cryptocurrency experts interviewed by CNN

    But that data is still only a partial picture of the problem. The Chinese chemicals industry is worth over a trillion dollars, according to some estimates, and comprises tens of thousands of companies, most of them doing legitimate business.

    “It’s impossible to know how many of [those companies] are actually sending chemicals over” to the US that can be used to make fentanyl, a former DEA agent who worked in Mexico told CNN. The former agent spoke on the condition of anonymity because they were not authorized to speak to the media.

    Barring more cooperation from the Chinese government on the issue, which US officials say has been limited, the Biden administration has sanctioned and secured federal indictments against several Chinese companies allegedly involved in the production of fentanyl. Federal agents, meanwhile, follow the money and look for opportunities to seize it.

    “You can at least try to pinch off the financial flow to [the Chinese companies] and then … follow that money trail to whether it’s the Mexican cartels or if it’s in Guatemala or other places, for the actual supply,” Koopman told CNN.

    Cryptocurrency has also allowed cartels to diversify the way they move money around the world. The cartels have a network of money launderers in dozens of countries, from Thailand to Colombia, the senior DEA official said.

    These money launderers, known as “spinners,” might receive drug money in one type of cryptocurrency and convert it to another to try to obscure the source of the funds.

    “They might take Bitcoin and then buy Ethereum with it, and then send the Ethereum to the cartel members,” the senior DEA official said, referring to different types of cryptocurrencies. “The cartels have insulated themselves so they’re not receiving the cryptocurrency directly.”

    The cartels also use “mixing” services, or publicly available cryptocurrency tools, to try to obscure the source of their digital money, the DEA official said. That process is also favored by North Korean hackers who launder stolen cryptocurrency to support Pyongyang’s weapons program, CNN investigations have found.

    The volatility of cryptocurrency means the cartels often quickly look to convert their crypto to cash by moving it through a series of virtual currencies, the senior DEA official told CNN.

    But there are moments in the laundering process where federal agents can strike. A cryptocurrency exchange serving a customer in Mexico might be headquartered in the US, allowing federal agents to issue a subpoena and potentially seize money.

    For Brown, the DHS agent in Arizona, the issue is personal: one of his employees had a family member who died of a fentanyl overdose after buying the drug online , he said.

    “My people are burned out, and yet they come to work and work exceedingly hard every day,” Brown told CNN.

    But he’s optimistic when the subject turns to high-tech methods to hunt the cartels.

    “Are they as anonymous as they think they are? Absolutely … not.”

    [ad_2]

    Source link

  • DEA employs new strategy in fight against fentanyl trafficking

    DEA employs new strategy in fight against fentanyl trafficking

    [ad_1]

    DEA employs new strategy in fight against fentanyl trafficking – CBS News


    Watch CBS News



    The Drug Enforcement Administration is using a new method in its fight against fentanyl by targeting the entire trafficking network. Nancy Cordes has details.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • U.S. sanctions Chinese suppliers of chemicals for fentanyl production

    U.S. sanctions Chinese suppliers of chemicals for fentanyl production

    [ad_1]

    Two Chinese businesses were sanctioned Friday by the United States after allegedly supplying precursor chemicals used to produce fentanyl to drug cartels in Mexico.

    “Illicit fentanyl is responsible for the deaths of tens of thousands of Americans each year,” said Brian E. Nelson, the Under Secretary for Terrorism and Financial Intelligence, in a Treasury Department news release announcing the sanctions. The department “will continue to vigorously apply our tools” to stop chemicals from being transferred, he said.

    The announcement comes on the same day the Justice Department charged 28 Sinaloa Cartel members in a sprawling fentanyl trafficking investigation. The indictments also charged four Chinese citizens and one Guatemalan citizen with supplying those chemicals. The same five were also sanctioned by the Treasury Department, according to its release.

    In recent years, the Drug Enforcement Administration has called on the Chinese government to crack down on supply chain networks producing precursor chemicals. DEA Administrator Anne Milgram told CBS News last year that Chinese companies are the largest producers of these chemicals.

    In February, Iowa Republican Sen. Joni Ernst accused China of “intentionally poisoning” Americans by not stopping the supply chain networks that produce fentanyl. 

    Vanda Felbab-Brown, a Brookings Institution senior fellow who has researched Chinese and Mexican participation in illegal economies said in testimony submitted to the House of Representatives Subcommittee on National Security, Illicit Finance, and International Financial Institutions there is little visibility into China’s enforcement of its fentanyl regulations, but it likely “remains limited.” 

    Law enforcement and anti-drug cooperation between the U.S., China and Mexico “remains minimal,” Felbab-Brown said in her testimony, and sanctions are one tool that may induce better cooperation.

    Sanctions ensure that “all property and interests in property” for the designated persons and entities must be blocked and reported to the Treasury.

    Chemical companies Wuhan Shuokang Biological Technology Co., Ltd and Suzhou Xiaoli Pharmatech Co., Ltd were slapped with sanctions for their contribution to the “international proliferation of illicit drugs or their means of production,” the Treasury Department said. 

    The Guatemalan national was sanctioned for their role in brokering and distributing chemicals to Mexican cartels.

    Caitlin Yilek and Norah O’Donnell contributed to this report.

    [ad_2]

    Source link

  • Biden administration declares fentanyl laced with xylazine ‘an emerging threat’ in the US | CNN

    Biden administration declares fentanyl laced with xylazine ‘an emerging threat’ in the US | CNN

    [ad_1]



    CNN
     — 

    The White House has declared that the powerful synthetic opioid fentanyl combined with xylazine – an animal tranquilizer that’s increasingly being used in illicit drugs – is an “emerging threat” facing the United States due to its role in the ongoing opioid crisis.

    Administration officials call the threat FAAX, for fentanyl-adulterated or -associated xylazine.

    The move, announced Wednesday, marks the first time in history that any administration has declared a substance to be an emerging threat to the country, said Dr. Rahul Gupta, director of the Office of National Drug Control Policy. The SUPPORT Act of 2018 established that the office has authority to declare such “emerging threats,” and no administration has used it until now. Last year, Congress declared methamphetamine an emerging drug threat but none have been declared by an administration previously. Under other agencies or in separate circumstances, concerns such as bioterrorism, infectious diseases or climate change may be identified as “emerging threats.”

    “This drug, which is an animal sedative, is being mixed with fentanyl and is being found in almost all 50 states now,” Gupta said Tuesday. “It’s become an important part for us to make sure that we’re declaring it an emerging threat.”

    Now that the administration has declared fentanyl combined with xylazine an emerging threat, it has 90 days to coordinate a national response. “We are working quickly to develop and implement a whole of government nationwide plan, with real deliverable action, that will save lives and will be published within 90 days of this designation,” Gupta said.

    Xylazine, also known as tranq or tranq dope, has been linked to an increasing number of overdose deaths in the United States due to its rising illicit use. Between 2020 and 2021, overdose deaths involving xylazine increased more than 1,000% in the South, 750% in the West and about 500% in the Midwest, according to an intelligence report released last year by the US Drug Enforcement Administration.

    And in some cases, people might not even know that xylazine was in the drug they used.

    Just last month, authorities at the DEA issued a public safety alert about the “widespread threat” of fentanyl mixed with xylazine, reporting that in 2022 approximately 23% of fentanyl powder and 7% of fentanyl pills seized by the DEA contained xylazine.

    Fentanyl, which has been driving the opioid crisis, is a fast-acting opioid, and people who use it illicitly say that adding xylazine can extend the duration of the high the drug provides.

    Xylazine is not an opioid. It is approved by the US Food and Drug Administration for use as a tranquilizer in veterinary medicine, typically in horses, but it is not approved for use in humans. And xylazine can do major damage to the human body, including leaving drug users with severe skin ulcers, soft-tissue wounds and necrosis – sometimes described as rotting skin – that can lead to amputation.

    “Xylazine is one of the contaminants in fentanyl, but there could be others,” Gupta said. “So, I think with the declaration of an emerging threat, we’re sending a clear message to producers and traffickers of illicit xylazine and illicit fentanyl that we’re going to respond quicker, we’re going to match the challenge of evolution of these drugs supply, and that we’re going to protect lives first and foremost.”

    Now that xylazine has been declared an emerging threat, some of President Biden’s $46 billion drug budget request to Congress can be used to respond.

    This year, the Biden administration announced that the President has called on Congress to invest $46.1 billion for agencies overseen by the Office of National Drug Control Policy to tackle the nation’s illicit drug crisis.

    If the budget request is not approved, there could be the option to reallocate money within the Office of National Drug Control Policy, but “we don’t want to be in a position where moneys that are being utilized for some other important aspect of saving lives has to be moved away for this purpose,” Gupta said Tuesday. “That is the reason we are asking Congress to act.”

    Such funds could be used to test drugs on the street for xylazine, collect data on FAAX, invest in care for people exposed to FAAX and develop potential treatments for a xylazine-related overdose.

    The medication naloxone, also known as Narcan, is an antidote for an opioid overdose, but people who have overdosed on a combination of opioids and xylazine may not immediately wake up after taking naloxone, as it may not reverse the effects of xylazine in the same way it does opioids.

    “We need to recognize, first of all, that there is a shift that is occurring from organic compounds and substances like heroin and cocaine to more synthetics,” Gupta said of the state of the nation’s illicit drug crisis.

    “Both the types of drugs have changed – from predominantly organic to predominantly synthetics – but the way drugs are bought and sold have also changed,” he said. “Now, all you need is a phone in the palm of your hand and a social media app to order and buy some of the most dangerous substances on planet Earth.”

    Xylazine is just one of the many adulterants – or substances that are typically added to others – found in the nation’s illicit drug supply.

    “All of a sudden, you can synthesize hundreds of compounds and kind of mix them together and see what does the best in the market,” Joseph Friedman, a researcher at the University of California, Los Angeles, told CNN in March. “People are synthesizing new benzodiazepines, new stimulants, new cannabinoids constantly and adding them into the drug supply. So people have no idea what they’re buying and what they’re consuming.”

    Some of these adulterants may be as simple as sugar or artificial sweeteners added for taste or additives or fillers that bulk up the drug. Sometimes, they may be contaminants left over from the manufacturing process.

    But all of these things can carry real-life health harms, says Naburan Dasgupta, an epidemiologist and senior scientist at the Gillings School of Global Public Health at the University of North Carolina, Chapel Hill.

    Like an opioid, xylazine can depress the respiratory system, so the risk of overdose multiplies when it’s combined with heroin or fentanyl.

    Also, “in the veterinary literature, we know that it causes a really bad severe form of anemia. And so when people are injecting heroin that’s contaminated with xylazine, they can end up with a near-fatal form of blood iron deficiency,” Dasgupta said in March. “We had one person here who ended up going to the hospital needing multiple blood transfusions. And it was all because of the xylazine.”

    US lawmakers are moving to classify xylazine as a controlled substance.

    In March, bipartisan legislation – the Combating Illicit Xylazine Act – was introduced in the House and Senate. It describes illicit xylazine as an “urgent threat to public health and safety” and calls for it to be a Schedule III drug under the Controlled Substances Act, a category on the five-level system for substances with moderate to low potential for physical or psychological dependence. Xylazine would be one level below opioids like fentanyl.

    “Our bipartisan bill would take important steps to combat the abuse of xylazine by giving law enforcement more authority to crack down on the illicit distribution of this drug, including by putting stiffer penalties on criminals who are spreading this drug to our communities,” Sen. Maggie Hassan, D-N.H., said in a statement in March.

    The bill would also require manufacturers to send reports on production and distribution to the DEA so the agency can ensure that the product is not being diverted to the black market.

    “This bill recognizes the dangers posed by the increasing abuse of animal tranquilizers by drug traffickers, and provides new tools to combat this deadly trend,” Sen. Chuck Grassley, R-Iowa, said in the statement.

    “It also ensures that folks like veterinarians, ranchers and cattlemen can continue to access these drugs for bona fide animal treatment.”

    [ad_2]

    Source link

  • The US sanctioned Chinese companies to fight illicit fentanyl. But the drug’s ingredients keep coming | CNN

    The US sanctioned Chinese companies to fight illicit fentanyl. But the drug’s ingredients keep coming | CNN

    [ad_1]



    CNN
     — 

    The seller, who went by the name Linda Wang, was curt when asked if she sold a chemical often used to create fentanyl.

    “That’s banned,” Wang replied, before quickly providing an alternative: “CAS79099 powder is best. U can have a try.” 

    After more than a week of back and forth, she seemed impatient. “Ok. 79099 powder in USA warehouse now…if you need. Pls order asap,” she wrote in a text message exchange.

    The interaction is part of a CNN investigation that explored whether US-sanctioned chemical companies in China are evading Washington DC’s crackdown on illicitly made fentanyl – finding at least one China-based company that had links to a sanctioned entity, and a seller eager to ship potential ingredients for the lethal drug.

    More than 100,000 Americans died from drug overdoses in 2021, and two-thirds of the fatalities involved synthetic opioids – much of it believed from illicitly made fentanyl, according to the Centers for Disease Control.

    The drug can be 50 times stronger than heroin and 100 times stronger than morphine – and pharmaceutical grade versions of it can be prescribed by doctors for severe pain. But illegally manufactured fentanyl has turbocharged the US’s opioid overdose crisis in the last decade, according to data from the CDC.

    Controlling the illegal trade of the drug has turned into a geopolitical headache for the Biden administration, as China’s vast chemicals market – which supplies the world with raw materials for everything from perfume to explosives– is also a major pipeline of the building blocks of fentanyl, known as fentanyl precursors, according to US officials. 

    Further complicating the fight against fentanyl is the sheer variety of precursors that can be used to make fentanyl and other illicit drugs. Most such precursors also have legitimate uses – including for medical research – and are perfectly legal to sell, making up part of the booming transnational trade.

    China has strict anti-drug policies domestically, but critics in the US say it is not doing enough to help monitor or regulate purchases from buyers aiming to use Chinese-made ingredients to manufacture illegal drugs overseas.

    In 2019, Beijing stepped up its crack down on the production and sale of finished fentanyl and its variants, but US-China anti-drug cooperation has since stalled amid disagreements on trade, human rights, the Covid-19 outbreak and Taiwan. Hopes that US Secretary of State Antony Blinken would bring up fentanyl during a planned visit to Beijing died in early February, when Blinken postponed his trip after a surveillance balloon from China floated over the continental US. 

    As the opioid crisis topped the domestic agenda in 2021, the US sanctioned four companies in China accused of exporting fentanyl or fentanyl precursor chemicals. Online commercial records suggest ties between one of those sanctioned companies, Hebei Atun Trading Co., Ltd., and another China-based company called Shanxi Naipu Import and Export Co., Ltd., that continues to sell fentanyl precursors legally.

    According to official public records in China, Hebei Atun Trading Co., Ltd., began liquidating in June 2021 and was formally dissolved in August that year. Shanxi Naipu Import and Export Co., Ltd. was registered in the same period, according to official records, and it shares a number of key things in common with Hebei Atun.

    For example, Hebei Atun’s still-active Facebook page once linked to a now-defunct website of Shanxi Naipu – which is where CNN found Wang’s phone number.

    The two companies’ websites are registered to the same email address, and at one time appeared to share an IP address. Today, Shanxi Naipu’s websites appear to be carbon copies of Hebei Atun’s since-deleted page – with the same navigation tabs, email address and stock photo of a pipette dropping amber-colored liquid into a cell tray. The Russian and Portuguese versions of the site list “Hebei Atun Trading Co. Ltd.” as their copyright holder.

    One post on a Shanxi Naipu website was titled, “Hebei ATUN Trading Co., Ltd. Wishes you a Happy New Year!” (sic). It has since been deleted. 

    When presented with CNN’s findings, Shanxi Naipu denied ties to Hebei Atun, saying, “we are not related at all.” In statements emailed to CNN, Shanxi Naipu said it had purchased the sanctioned company’s Facebook account, email and cell phone number in order to “attract internet traffic.”

    Shanxi Naipu also denied selling the fentanyl precursor that Wang offered by text, and stressed that everything they sell is legal, and said that they were taking steps to stop the repercussions from the apparent links to Hebei Atun.

    “To prevent further impact from Hebei Atun, we have immediately removed relevant promotional websites and platforms,” the company said in an emailed statement.”

    Logan Pauley, a China analyst who tracks criminal and drug networks, told CNN, “It’s easy on the Chinese side to start a new company to copy and paste the same text that you’re posting on social media or you’re posting on a trade website, and then just to recreate the same operation over and over again.”

    And Gary Hufbauer, trade expert at the Peterson Institute for International Economics and former US treasury official, likens it to a game of cat-and-mouse. While the US government can add an entity to its sanctions list “overnight,” said Hufbauer, there may not be the resources in the US Treasury’s Office of Foreign Assets Control, which enforces sanctions, to keep tabs on new companies that may leverage sanctioned companies’ branding or operations. 

    In a statement to CNN, a spokesperson for the US Treasury said it “had not hesitated” to go after “bad actors” – citing the four sanctioned Chinese companies – and would continue to sanction companies and individuals involved in the drug trade.

    “Treasury continues to monitor the effects of our designations,” they said. “If additional information becomes available that can assist sanctions compliance efforts, when appropriate, we provide that information to industry and/or the public.”

    Asked if Beijing was knowingly lax in its efforts to stem the flow of precursor chemicals from its country, the Chinese Foreign Ministry pointed out that most were not controlled substances, in a lengthy statement that also questioned US efforts to treat addiction and demand for opioids.

    “China has always strictly controlled precursor chemicals in accordance with international conventions and domestic laws. The US side’s so-called ‘fentanyl precursors,’ a small number of them are listed substances by the United Nations, and China has always been resolute in implementing the listed measures. But most of the rest are common chemicals that are not listed by the United Nations, China or even the United States itself,” it said in a written statement to CNN.

    “Government departments do not have the right or the possibility to regulate non-listed chemicals and common commodities,” it added.

    The ministry statement went on to highlight China’s harsh domestic penalties on drug trade and consumption. “The Chinese people deeply resent drugs. the Opium War was the beginning of China’s modern history of humiliation. The Chinese government has always cracked down on drug crime, and China is a no-go area for international drug dealers.”

     Such unregulated precursors, like the one offered by Wang, are not illegal to sell but can be used in the manufacture of illicit substances like fentanyl, methamphetamine, and cocaine.

    Several precursors used to create fentanyl have been put under international control since 2017, but a savvy chemical engineer can combine legal precursors further up the synthesis chain to make similar compounds.

    “What we have seen illicit chemists doing now is that certain components of the synthesis are now … harder for them to purchase, so what they’re doing now is they’re buying compounds that are structurally very, very similar,” Alexandra Evans, a forensic chemist with the D.C. Department of Forensic Sciences, told CNN from her lab in the US capital.

    Or they can create fentanyl analogues, substitutes that are chemically similar to fentanyl and which has made the crisis more deadly in recent years. One fentanyl analogue was found to be 10,000 times stronger than morphine, according to a 2021 US government report.

    Controlling the stream of chemicals has turned into a deadly game of whack-a-mole – where manufacturers are able to use a variety of precursors to synthesize fentanyl and its analogues faster than either can be identified, banned, or regulated. 

    Many of the building blocks to fentanyl have benign purposes and are legal to buy, but a menu Wang sent of Shanxi Naipu’s chemical products for sale appeared designed to support illegal drug manufacture, according to a synthetic chemist who analyzed the list for CNN. 

    It was “obviously a list curated to help people create illicit drugs,” Lyle Isaacs, a professor in the Department of Chemistry and Biochemistry at the University of Maryland, told CNN of the more than 25 chemical compounds on the menu. 

    At least three compounds on the list could be made into fentanyl, he said. One of the compounds, CAS 79099-07-3, also known as 1-Boc-4-piperidone, was what Wang offered to sell CNN; the other two compounds also have legitimate uses and can be found, for example, in academic laboratories researching future medicines, Isaacs said. 

    Still more compounds on the list appeared to be building blocks for meth, ecstasy, ketamine, and the cutting of cocaine, as well as over-the-counter drugs like paracetamol, a common pain medication that can also be used to cut heroin and other narcotics, he added. 

    Asked about the list, Shanxi Naipu reiterated in its statement to CNN that all products on it are legal in China, stating: “We are not professional chemists but just a trading company. Even though we don’t have an intimate knowledge of the composition and use of thousands of chemicals, we have always strictly ensured the legality of our products!”

    Attempts to contact Wang through the company for comment were not successful, and the company said in its statement that she no longer works for them.

    There are measures that responsible chemical sellers can take to avoid their products being used for illegal drugs.

    Identity checks are a hallmark of reputable sellers, said a former Drug Enforcement Administration (DEA) official. The source spoke to CNN on the condition of anonymity because they were not authorized to speak to the media. To sell non-listed chemicals, a good-faith seller would normally ask a buyer about the intended use of the compound, and whether the buyer had the backing of a company or institution, such as a research organization or university.  

    American buyers of regulated chemicals require licenses from the DEA, depending on how hazardous they are. Reputable sellers may also ask for tax identifications even for chemicals that are not controlled, like precursor materials, the source said.

    At no point in the conversation was Wang aware, nor did she ask for the identities of the CNN reporters speaking to her or what CNN planned on using it for. She even offered a “door to door” precursor delivery service via warehouses in the US or Mexico – locations that CNN has been unable to verify.

    In its statement to CNN, Shanxi Naipu denied that it had warehouses in either country.

    The small quantity of precursor needed to manufacture fentanyl ultimately makes shipments destined for illicit ends hard to catch at the border, points out Martin Raithelhuber, an illicit synthetic drugs expert at the United Nations Office on Drugs and Crime.

    “You have hundreds of thousands of tonnes (of chemicals in a shipment), and you are looking for a few kilograms, which are sufficient to produce a supply of millions of doses (of fentanyl),” he said. 

    Since China banned the production of fentanyl and related substances in 2019, Mexican criminal organizations have largely taken control of the drug’s production and sale, smuggling finished fentanyl to consumers in the US, according to a 2022 report from the Congressional Research Service.

    Mexico is now the source of “the vast majority” of meth, heroin and illicit fentanyl seized in the US, according to the US International Narcotics Control Strategy Report (INCSR) released in March 2023. “In 2022, the United States identified Mexico as the sole significant source of illicit fentanyl and fentanyl analogues significantly affecting the United States,” it reads.

    “Criminal elements, mostly in the People’s Republic of China, ship precursor chemicals to Mexico, where they are used to produce illicit fentanyl,” Dr. Rahul Gupta, director of the White House’s Office of National Drug Control Policy, told the Senate Foreign Relations Committee earlier this year. 

    “The only limit on how much fentanyl they can make is the amount of precursor chemicals they can get,” DEA Administrator Anne Milgram told CNN in early March.

    The Biden administration has taken aim at these groups and in February sanctioned a network of Sinaloa Cartel members and associated entities for their involvement in the fentanyl and methamphetamine trade. 

    Mexico’s law enforcement has also fought the trade, seizing and impounding hundreds of kilos of fentanyl precursors and pills – including a cache of over a million potential fentanyl pills in the Mexican border city of Tijuana on March 13.

    Ultimately, tackling fentanyl requires close coordination between the US, Mexico, and China. Even if countries like Mexico had the best national control measures, international cooperation is needed to understand “which flows are the ones we need to watch or [be] worried about,” Raithelhuber said.

    Former DEA official Matthew Donahue told CNN he would like to see Mexico do more, including cracking down on properties and other assets of those involved in the drug trade.

    But as the US pressures other governments to help slow the flow of illicit fentanyl, relations between the three countries have turned into a three-way blame game.

    Following the kidnapping of four Americans in a Mexican border town by cartel members in early March, US Republicans called for the US military to be allowed to fight cartels and destroy drug labs in Mexico – something Mexican President Andrés Manuel López Obrador called “an offense to the people of Mexico.” 

    “We are not a protectorate of the United States or a colony of the United States. Mexico is a free, independent, sovereign country. We don’t take orders from anyone,” López Obrador said at a news conference on March 9. 

    Washington has also called on Beijing to do more, with the latest US INCSR report describing China’s oversight functions as “poorly staffed and under-resourced to oversee its massive chemical industry.” Though it acknowledges Beijing’s harsh penalties for drug trafficking, the report laments ineffective controls on shipment labeling, customer vetting and pill-making equipment.

    The Ministry of Foreign Affairs’ statement to CNN emphasizes its “stringent” control of listed chemicals that could be used for drug-making and argues that Beijing has “improved” several “regulatory mechanisms such as end-user verification, leakage monitoring, and source backtracking, and has strengthened management of more than 200,000 chemical companies.”

    Both China and Mexico have called on the US to do some soul-searching about demand for illicit fentanyl.

    “US legislators and the authorities there are not doing their job because they are not addressing the causes (of addiction); there are no care programs for young people in the US,” López-Obrador said last week.

    “Using China as a scapegoat will not solve the drug crisis in the United States … ,” the Chinese Foreign Ministry’s statement to CNN read. “We advise the US side to reflect on itself, stop shifting blame, strengthen domestic prescription drug control, enhance publicity on the dangers of drugs, and take practical measures to reduce domestic drug demand.”

    Prescription opioids like oxycodone and hydrocodone – which have a similar chemical structure to heroin and fentanyl – were major contributors to the early opioid crisis in the US. Pharmaceutical giants, notably Purdue Pharma, downplayed the potentially addictive properties of the drugs and incentivized US doctors to prescribe the painkillers. But prescribing was curtailed as overdoses from prescription opioids climbed and now waves of heroin and illicit fentanyl took over, making the crisis far more deadly. 

    Amid the recriminations, fentanyl products continue to pour through US borders and Americans continue to die. 

    To raise awareness of the human toll, the US Drug Enforcement Administration last year created “The Faces of Fentanyl” exhibit at its headquarters in Arlington, Virginia where families can submit a photo of a loved one lost to the fentanyl crisis. So far more than 5,000 photos have been submitted.

    “We can’t be desensitized” to the number of lives lost to drug overdoses,” Donahue, the former DEA official, said. “The pain and suffering that these families are going through. That has got to mean something.” 

    [ad_2]

    Source link

  • Combating narco-subs and narco-terrorism in the U.S. and abroad

    Combating narco-subs and narco-terrorism in the U.S. and abroad

    [ad_1]

    Combating narco-subs and narco-terrorism in the U.S. and abroad – CBS News


    Watch CBS News



    After two suspected “narco-subs” were found by law enforcement officials, new questions have been raised about how submarines are being used to transport drugs from country and country. Derek Maltz, former director of the Drug Enforcement Administration’s special operations division, joins “CBS News Mornings” to discuss.

    Be the first to know

    Get browser notifications for breaking news, live events, and exclusive reporting.


    [ad_2]

    Source link

  • More than 4.5 million fentanyl pills, 3,000 pounds of methamphetamine seized in Arizona investigation, DEA says | CNN

    More than 4.5 million fentanyl pills, 3,000 pounds of methamphetamine seized in Arizona investigation, DEA says | CNN

    [ad_1]



    CNN
     — 

    Arizona authorities targeting the Sinaloa drug cartel have seized narcotics estimated to be worth more than $13 million, including more than 4.5 million fentanyl pills, 3,100 pounds of methamphetamine and large quantities of heroin, cocaine and fentanyl powder, according to the Drug Enforcement Administration.

    In a news release, the agency said the seizure was the culmination of a three-year-long investigation during which 150 people had so far been charged.

    “The fentanyl seized represents more than 30 million potentially lethal doses,” the DEA said, announcing the seizure in partnership with the Tempe Police Department and Arizona Attorney General Kris Mayes.

    Authorities displayed some of the recovered narcotics at a joint news conference Thursday, attended by CNN affiliate KNXV.

    “The sample you see here today is staggering. There are over 4.5 million fentanyl pills, over 140 pounds of fentanyl powder, over 135 kilos of cocaine, over 3,000 pounds of methamphetamine, 35 kilos of heroin, 49 firearms and over $2 million in cash,” Interim Tempe Police Chief Josie Montenegro told reporters.

    Montenegro said the substances recovered “would be poisoning members of our community, including our youth and vulnerable population,” had the seizures not been made.

    “In addition, the dangers and crimes associated with illegal drugs would be plaguing our community,” Montenegro added.

    According to authorities, “numerous” people were taken into custody in the bust. At this time, authorities do not plan on releasing the names of those involved because it is a continuing investigation, according to Montenegro.

    Phoenix DEA Special Agent in Charge Cheri Oz said investigators are “laser-focused” on the Sinaloa cartel.

    “I want to be crystal clear, the drugs in this room and the drugs that are flooding Arizona every single day are sourced primarily by one evil as the Sinaloa drug cartel,” she said at the news conference. “We are laser-focused on the Sinaloa drug cartel and we will defeat them. We will not stop.”

    Oz also praised the efforts of DEA agents and other officers over the last three years. “Their hard work and tenacity is responsible for removing these deadly drugs before they poisoned our family, our friends and our neighborhoods,” she said.

    The country is struggling with a decades-long opioid epidemic in which fentanyl has become the most commonly used drug involved in overdoses.

    Pharmaceutical fentanyl is a synthetic opioid intended to help patients manage severe pain. It is 50 to 100 times more potent than morphine, and typically prescribed in the form of skin patches or lozenges. But most recent cases of fentanyl-related harm, overdose, and death in the United States are linked to illegally made fentanyl, according to the US Centers for Disease Control and Prevention.

    Deaths involving synthetic opioids increased by 22% in 2021, according to CDC data, and in 2022, there were about 181,806 nonfatal opioid overdoses recorded in the United States.

    [ad_2]

    Source link

  • Feds seek to limit telehealth prescriptions for some drugs

    Feds seek to limit telehealth prescriptions for some drugs

    [ad_1]

    The Biden administration moved Friday to require patients see a doctor in person before getting attention deficit disorder medication or addictive painkillers, toughening access to the drugs against the backdrop of a deepening opioid crisis.

    The proposal could overhaul the way millions of Americans get some prescriptions after three years of relying on telehealth for doctor’s appointments by computer or phone during the pandemic.

    The Drug Enforcement Administration said late Friday it plans to reinstate once longstanding federal requirements for powerful drugs that were waived once COVID-19 hit, enabling doctors to write millions of prescriptions for drugs such as OxyContin or Adderall without ever meeting patients in person.

    Patients will need to see a doctor in person at least once to get an initial prescription for drugs that the federal government says have the the most potential to be abused — Vicodin, OxyContin, Adderall and Ritalin, for example. Refills could be prescribed over telehealth appointments.

    The agency will also clamp down on how doctors can prescribe other, less addictive drugs to patients they’ve never physically met. Substances like codeine, taken to alleviate pain or coughing, Xanax, used to treat anxiety, Ambien, a sleep aid, and buprenorphine, a narcotic used to treat opioid addiction, can be prescribed over telehealth for an initial 30-day dose. Patients would need to see a doctor at least once in person to get a refill.

    1670371617286.png
    Patients will need to see a doctor in person at least once to get an initial prescription for drugs that the federal government says have the the most potential to be abused. 

    CBS News


    Patients will still be able to get common prescriptions like antibiotics, skin creams, birth control and insulin prescribed through telehealth visits.

    The new rule seeks to keep expanded access to telehealth that’s important for patients like those in rural areas while also balancing safety, an approach DEA Administrator Anne Milgram referred to as “expansion of telemedicine with guardrails.”

    The ease with each Americans have accessed certain medications during the pandemic has helped many get needed treatment, but concerns have also mounted that some companies may take advantage of the lax rules and be overprescribing medications to people who don’t need them, said David Herzberg, a historian of drugs at the University of Buffalo.

    “Both sides of this tension have really good points,” said Herzberg. “You don’t want barriers in the way of getting people prescriptions they need. But anytime you remove those barriers it’s also an opportunity for profit seekers to exploit the lax rules and sell the medicines to people who may not need them.”

    U.S. overdose deaths hit a record in 2021, about three-quarters of those from opioids during a crisis that was first spun into the making by drug makers, pharmacies and doctors that pushed the drugs to patients decades ago. But the grim toll from synthetic opioids like fentanyl far outstripped deaths related to prescription drugs that year, according to Centers for Disease Control Data. Fentanyl is increasingly appearing on the illicit market, pressed into fake prescription pills or mixed into other drugs.

    The proposed rules deliver a major blow to a booming telehealth industry, with tech startups launching in recent years to treat and prescribe medications for mental health or attention deficit disorders. The industry has largely benefitted from the reprieve on in-person visits for drugs brought on by the pandemic, although some national retailers stopped filling drug orders generated by some telehealth apps over the last year.


    Justice Department investigating online mental health provider Cerebral

    08:17

    The DEA has grown increasingly concerned over the last two years that some of those startup telehealth companies are improperly prescribing addictive substances like opioids or attention deficit disorder medication, putting patients in danger, a DEA official told The Associated Press on Friday.

    The official said the agency plans to have the new rule in place before the COVID-19 public health emergency expires on May 11, which will effectively end the loosened rules. That could mean people who may seeking treatment from a doctor who is hundreds of miles away need to start developing plans for in-person visits with their doctors now, pointed out Boston-based attorney Jeremy Sherer, who represents telehealth companies. Patients will have six months to visit their doctor in person when the regulation is enacted.

    “Providers and their patients need to know what that treatment is going to look like moving forward and whether, once the public health emergency ends in May, if they’re going to need to figure out a way to have a visit in person before continuing treatment, and that can be a real challenge,” he said.

    Many states have already moved to restore limitations for telehealth care across state lines. By October, nearly 40 states and Washington, D.C., had ended emergency declarations that made it easier for doctors to see patients in other states.

    [ad_2]

    Source link

  • Fentanyl seizures rise at U.S.-Mexico border — here’s why

    Fentanyl seizures rise at U.S.-Mexico border — here’s why

    [ad_1]

    The spike in fentanyl-related overdose deaths in the U.S. has fueled a national conversation and a redoubling of the government’s efforts to curb its smuggling. In 2021, 90% of some 80,000 opioid-related deaths involved fentanyl, federal statistics show.

    Most fentanyl is being smuggled,  into the U.S. along the southern border, often in vehicles driven by American citizens, as cartels and other criminal groups in Mexico have turned the production of the synthetic opioid into a clandestine industry that has become the primary source of fentanyl in the U.S., according to the Drug Enforcement Agency (DEA). 

    Since President Joe Biden took office, Republicans have sought to link the spike in fentanyl-related overdose deaths with the record numbers of migrants who have entered U.S. custody along the Mexican border. The Biden administration’s handling of a historic influx of illegal border crossings, Republican lawmakers claim, has allowed fentanyl to be smuggled into the U.S. at higher rates and fueled the opioid crisis.

    The debate over how the deadly drug is being smuggled was on full display earlier this week, when the Republican-led House of Representatives held its first hearing on U.S. border policy.

    While no Biden administration officials were called to testify, House Judiciary Committee Democrats accused Republicans of spreading misinformation. “What I find particularly pernicious is the attempt to conflate the issues of migrants seeking asylum through our legal processes with the very real scourge of fentanyl trafficking,” said Rep. Mary Gay Scanlon, Democrat of Pennsylvania.

    “Do you care precisely whether or not fentanyl is coming through ports of entry or between ports of entry when your family was directly impacted because fentanyl is flooding into our communities?” said GOP Rep. Chip Roy, of Texas. 

    During a briefing with reporters Thursday, Homeland Security Secretary Alejandro Mayorkas said it was “unequivocally false that fentanyl is being brought to the United States by non-citizens encountered in between the ports of entry who are making claims of credible fear and seeking asylum.”

    “The vast, vast majority is sought to be smuggled through the ports of entry and tractor-trailer trucks and passenger vehicles,” Mayorkas added.

    While successful fentanyl smuggling rates aren’t calculated by the government, seizures of fentanyl along the southern border have in fact risen sharply in recent years. Experts say only a fraction of fentanyl is seized by Border Patrol agents between the ports of entry, with virtually none transported by migrants seeking asylum within the United States.

    “People just don’t believe that others would be so brazen as to bring drugs through a legal crossing point where they know there’s a potential for them to be checked. They just think logically, it makes more sense to try to sneak [them] in,” said David Bier, associate director of immigration studies at the Cato Institute. “It’s actually a lot easier for Border Patrol to spot a human crossing a border than it is for an inspector to spot drugs within a tractor-trailer full of goods.”

    Where is fentanyl being seized?

    According to the DEA, most of the fentanyl is smuggled over land across the U.S.-Mexico border. Smaller amounts are smuggled by air from China.

    Customs and Border Protection (CBP), the agency responsible for interdicting illicit drugs along the U.S. borders, has reported that the vast majority of its fentanyl seizures along the southern border have occurred at ports of entry, where officials screen returning American citizens, foreign travelers and commercial trucks. 

    In fiscal year 2022, 84% of the 14,104 pounds of fentanyl seized along the Mexican border were detected by officers at ports of entry overseen by the Office of Field Operations, a CBP branch, according to government data.

    On the other hand, Border Patrol, which apprehends migrants who enter the U.S. illegally, seized 2,200 pounds of fentanyl, or 16% of all fentanyl seized along the southern border, in fiscal year 2022. Moreover, many of those seizures occurred at interior checkpoints, where Border Patrol agents screen commercial and passenger vehicles.

    How much fentanyl is entering the United States? How many Americans are dying?

    Last year, the DEA seized enough fentanyl to kill every American — more than 50 million fentanyl-laced pills and over 10,000 pounds of fentanyl powder. 

    More than 70,000 people died of overdose from synthetic opioids alone in 2021, according to the CDC — a number representing two out of three of all fatal drug overdoses and more lives lost than the combined equivalent of U.S. military personnel killed during the wars in Vietnam, Iraq and Afghanistan.

    During the pandemic, from 2019-2021, annual deaths from fentanyl nearly doubled.

    Along with the COVID-19 pandemic, overdose deaths have driven average life expectancy down in the U.S. over the past two years.

    Appearing before the House Judiciary Committee on Wednesday, Brandon Dunn, co-founder of “Forever 15,” a nonprofit group dedicated to raising awareness about fentanyl poisoning said his son “was murdered by a drug dealer selling counterfeit Percocet pills. The pill contained no Percocet, just 8 milligrams of fentanyl — four times the DEA’s estimate of a lethal dose.

    Dunn told lawmakers that parents suffering a similar loss have encouraged him to “come up here and let people know this is a border issue, not an immigration issue.”

    Who is smuggling fentanyl into the U.S.?

    Years ago, at the start of the opioid epidemic, direct flows of fentanyl came primarily from China. Nowadays, officials say the larger challenge is curbing Chinese-sourced fentanyl precursors from entering a U.S.-bound pipeline.

    “We were originally seeing a lot more fentanyl coming in through international mail facilities pre-pandemic,” said a CBP official granted anonymity to speak openly about the challenge. “The majority of it is now coming in through the southern border field offices and ports of entry.”

    Mexican cartels and transnational criminal organizations producing synthetic opioids next door are now largely responsible for fentanyl production, according to the DEA. They typically tried to smuggle fentanyl into the U.S. on vehicles entering official ports of entry along the southern border.

    For years, the Sinaloa Cartel controlled most trafficking across the U.S.-Mexico border. But officials from DHS’ investigative arm, Homeland Security Investigations (HSI) tell CBS News they’re tracking an uptick in activity by the Jalisco New Generation Cartel or CJNG. “They [also] have the contacts to China and then furthermore, the distribution networks to get things across the United States, the smuggling networks,” one official added.

    But these criminal networks rely on the cooperation of Americans, too. Data from the U.S. Sentencing Commission shows that between 2017–2021, 86% of fentanyl trafficking offenders were American citizens.

    According to officials at Homeland Security Investigations, a DHS branch, cartels routinely “utilize, organize and recruit American citizens” to smuggle drugs into the U.S., but the individuals working to transport synthetic opioids are not typically high-ranking members within a criminal network.

    Have fentanyl seizures along the southern border increased?

    At the start of the COVID-19 pandemic, from 2019-2021, fentanyl seizures at ports of entry nationwide quadrupled.

    The U.S. government’s ban on most legal cross-border traffic amid the public health emergency prompted a switch to the easier-to-conceal synthetic opioid, fentanyl.

    “Closures of ports of entry massively restricted the amount of cross border travel during the pandemic, which means that in order to supply the same market, [organizations] either needed a lot more trips into the United States, a lot more smugglers to make those trips, or you needed to switch [to] the more potent substance. That’s actually what happened very shortly after travel was restricted,” said Bier. “The amount of fentanyl being trafficked increased substantially.”

    The synthetic opioid is about 50 times more potent than heroin, according to the DEA.

    “This is not like the old days of [criminals] smuggling the big heavy marijuana bales — where you had to bring a lot of it in to make a profit,” a CBP official said. “With fentanyl, a little bit goes a long way.”

    In fiscal years 2021 and 2022, CBP officials at ports of entry carried out 91% and 83% of all fentanyl seizures along the southern border, respectively. 

    That disparity has only grown in recent months. Last December, CBP seized nearly 4,500 pounds of fentanyl – more than 8 times the amount seized during the same month in 2022. Of the 4,471 pounds of fentanyl captured by CBP, less than 5 pounds – roughly 0.1% – were discovered by Border Patrol agents.

    Do record migrant arrivals impact drug flows?

    U.S. government data and federal law enforcement accounts reveal fentanyl is largely smuggled into the country at ports of entry in coordination with cartels and transnational criminal groups.

    But federal law enforcement concedes that the Department of Homeland Security is working with a “finite number of resources” to tackle simultaneous challenges of record-breaking fentanyl trafficking and migrants seeking asylum in the United States.

    “If we have a group of 200 migrants turn themselves in, we of course have to process and transport them, etc.,” one CBP official said. “When we’re doing that, we don’t necessarily know what’s going on the rest of the border.”

    In interviews with CBS News, DHS officials expressed a greater need for resources, including personnel and technology enabling greater “situational awareness” at the U.S.-Mexico border.

    What’s next?

    It’s not just fentanyl pills and powder. Federal law enforcement is now tracking precursor chemicals used to make fentanyl – including some that are legal.

    Authorities have also taken note of recent phenomena of unwitting drivers pushing drugs over the southwest border. “What we’re seeing more and more at the southwest border is people that are coming across and not knowing, but the drugs have been placed in the vehicle,” a law enforcement official told CBS News. “[Criminals] basically break into the vehicle in Mexico, conceal drugs and attach a GPS tracker to the vehicle, then find it later and recover the product.”

    CBP has witnessed a “tremendous uptick” in the use of unmanned aerial systems or drones, designed for contraband drop-offs. In fiscal year 2022, CBP detected more than 2,200 drones engaged in drug-related activity at both the northern and southern borders.

    To bolster scanning at ports of entry, the U.S. government has pledged more than half a billion dollars to add more advanced “non-intrusive inspection” technology though the program has been slow to roll out. CBP officials have acquired approximately 135 non-intrusive inspection systems, though just 10 have been deployed to operational locations in Texas, Arizona and California.

    DHS is now accepting bids from contractors to maximize the use of artificial intelligence in non-intrusive scanning equipment, Secretary Mayorkas said Thursday.

    Trying to stop chemical precursors from entering supply chains in the U.S. and Mexico is a heavy investigative lift for federal law enforcement. “China is the leader in sending precursors. And what we’re seeing is that those are generally landing in Mexico,” said U.S. officials, who say they’ve also identified a small number of labs within the U.S. that rely on precursors.

    The U.S. is “receiving good cooperation from the Mexicans,” Mayorkas said Thursday, with transnational criminal investigative units “delivering results not just in Mexico but elsewhere.” 

    “One does not remain a transit country for long before one becomes a victim country as well,” Mayorkas added.

    Still, experts and federal officers alike concede that law enforcement is only a fraction of the solution needed to address the fentanyl crisis.

    “Any kind of further crackdown on the border will just further shift the market to a more potent and more dangerous alternative,” Bier said, pointing toward harm reduction models designed to empower physicians and users to manage addiction. “Everything must be done within the United States to reduce the demand and the collateral consequences of people using this dangerous substance.”

    [ad_2]

    Source link

  • Tracking the opioid crisis: Inside the DEA’s secret lab | CNN

    Tracking the opioid crisis: Inside the DEA’s secret lab | CNN

    [ad_1]

    Watch CNN Films’ “American Pain” at 9 p.m. ET Sunday, February 5.



    CNN
     — 

    Sitting among the warehouses of Dulles, Virginia, is one of the US Drug Enforcement Administration’s forensic labs. It’s one of eight across the country where scientists analyze illegal drugs and try to stay ahead of what’s driving deadly overdoses.

    Starting in the late 1990s with overprescribing of prescription narcotics, the opioid epidemic has continued to plague the United States for decades. What has changed is the type of drugs that have killed more than half a million people during the past 20 years.

    CNN was granted rare access to the secret lab where the DEA tests seized illicit drugs to understand what’s coming next.

    “The market is constantly changing, so we are trying to do everything we can from a science base to keep up with that,” Scott Oulton, deputy assistant administrator of the DEA’s Office of Forensic Sciences, told CNN Chief Medical Correspondent Dr. Sanjay Gupta.

    Holding a white bag of fentanyl precursor powder – one of the chemicals used to make the opioid – Oulton explained that the illicitly made painkiller continues to be a dominant presence in the drugs officials are finding.

    “This kilogram can be converted into fentanyl to make approximately 800 grams,” he said. “So it doesn’t take that much material, it’s fairly cheap, it’s inexpensive to obtain.”

    Fentanyl is the deadliest drug in the United States, and it’s often found in combination with other illicit drugs, including cocaine and heroin. But increasingly, fentanyl is showing up in illicit pills disguised as common prescription drugs like oxycodone, hydrocodone, even Adderall.

    Users buying drugs on the street that look like prescription pills may end up with a highly potent, potentially deadly drug they never intended to take.

    “Over 99% of what we see are fake. They contain fentanyl,” Oulton says of the pills that the agency is seizing.

    The 800 grams of fentanyl that Oulton held could be turned into 400,000 to 500,000 potentially lethal pills.

    As more and more of these lethal pills circulate, the opioid epidemic is reaching more of the population.

    Deena Loudon of Olney, Maryland, is among those living with its effects.

    “I truly love sharing Matthew with the world,” Loudon says as she flips through pictures of her son.

    One of her favorite memories is Matthew playing hockey – what Loudon calls his happy place.

    Matthew Loudon's mom says he turned to drugs after struggling with anxiety.

    But she also recalls his struggles with anxiety, which led him to turn to drugs. He started dabbling in them in the 10th grade. By the following year, his grades began to fall, and he couldn’t keep them high enough to stay in hockey.

    “He was using Xanax to help self-medicate himself and I think to help get rid of some of that angst so he could live somewhat of a normal life,” Loudon said.

    Matthew was always honest, almost to a fault, Loudon says. “He told me he tried everything. Like everything. Heroin, meth, crack, you name it, cocaine, whatever – until I guess he found what made him feel the best, and it was Xanax.”

    And as much as a mother can worry, Loudon says, Matthew always tried to reassure her. “I know what I’m doing,” he would tell her.

    She had heard about fentanyl showing up in pills in their area.

    “But you don’t ever think it’s going to happen to you,” Loudon said.

    She said they even had a conversation about fentanyl the day before he died. “I was sort of naive, wanting to stick my head in the sand and thinking ‘I bet he does know what he’s doing.’ ”

    On November 3, 2020, she found 21-year-old Matthew on the floor of their basement.

    Matthew’s autopsy report lists his cause of death as fentanyl and despropionyl fentanyl intoxication.

    “I don’t say he overdosed. I say he died from fentanyl poisoning. … Truthfully, like, at the end of the day, to me, he was murdered, right? Because he asked for one thing. They gave him something different. And it took his life.”

    For a parent, she said, the hardest thing is burying their child. It’s a pain she speaks out about in hopes of keeping other families safe.

    “It’s Russian roulette,” she warns them. “You never know what you’re gonna get.”

    The number of pills the DEA has seized skyrocketed in just three years, from 2.2 million in 2019 to 50.6 million in 2022.

    The sheer volume of pills has been one of the biggest challenges for the DEA’s lab, Oulton says. As the fentanyl threat continues to grow, the Virginia facility is expanding to accommodate the analysis needed.

    The lab can test for something as simple as the presence of fentanyl, but something called the purity of the pill also offers important insight. This means how much fentanyl is actually in one of these illicit pills.

    “Lately, we’ve been seeing a purity increase over the last year, where we used to say roughly four out of the 10 seizures that we were receiving would contain a lethal dose of greater than 2 milligrams. As of October last year, we started reporting that we’ve seen an uptick. Now we’re saying that six out of 10 of the seizures that we’re receiving contain over 2 milligrams,” Oulton said.

    He says they’re finding an average of 2.3 milligrams of fentanyl in each pill.

    Two milligrams may be the cutoff for what is considered lethal, but Oulton says that doesn’t necessarily mean a pill with 1.99 milligrams of fentanyl can’t be deadly.

    “One pill can kill” is his warning.

    “The message I would like to send out is, don’t take it,” he said. “Don’t take the chance. It’s not worth your life.”

    Oulton says he and his team are constantly finding new and different drugs and substances in pills – things they’ve never seen before.

    One machine in the lab is almost the equivalent of an MRI in a medical office, showing the structure and detail of a pill.

    “We will do what we call structural elucidation to determine that this is a different version of a fentanyl that’s got a new compound and molecule that’s been added to it,” Oulton said.

    They’ve seen “hundreds and hundreds of unique combinations,” he said.

    “We’ll see one that contains fentanyl, one with fentanyl and xylazine, one with fentanyl and caffeine, one with fentanyl and acetaminophen, and you don’t know what you’re getting.”

    Xylazine, a veterinary tranquilizer, poses a unique problem. It’s not an opioid, so even when it’s mixed with fentanyl, drugs designed to reverse an opioid overdose may not work.

    Narcan or naloxone, one of the more common overdose-reversing drugs, has become increasingly necessary as the prevalence and potency of illicit drugs increases. About 1.2 million doses of naloxone were dispensed by retail pharmacies in 2021, according to data published by the American Medical Association – nearly nine times more than were dispensed five years earlier.

    Oulton wants to be clear: The problem Isn’t with pills prescribed by your doctor and dispensed by a pharmacy – it’s the pills on the illicit market.

    Those, Matthew’s mother warns, are easy to get.

    “The first pills [Matthew] got was in high school. And it was just flipping out, floating around, and it was easy for him to get his hands on,” she said.

    Loudon’s message for parents now: Keep your eyes open.

    “Just be mindful of what your children are doing. You just just have to keep your eyes open. And even sometimes, when you keep your eyes open, you can miss some of the warning signs, but I think a parent knows their child best, so just keep talking.”

    [ad_2]

    Source link